Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dose Conversion from Darbepoetin Alfa to Epoetin Alfa in CKD Anemia
NCT00495365Phase 4Terminated
- Sponsor
- Ortho Biotech Inc.
- Start
- Jun 2003
- Modality
- Biologic, rProtein (Recombinant Protein)
01
Overview
A Phase 4 trial of epoetin alfa in anemia of chronic kidney disease (CKD-A), sponsored by Ortho Biotech Inc.. Started Jun 2003; status: terminated.
02
Drugs
epoetin alfa
03
Conditions
anemia of chronic kidney disease (CKD-A)
Beyond the preview
Go deeper on NCT00495365.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00495365.